The Duke Chronicle has the story of Duke Medicine’s response to the massive cuts to federal funding that are impacting science and medicine:
Set to go in effect in 2026, the proposed policy would apply to the school’s basic science units, which include departments ranging from biochemistry to neurobiology and various centers and institutes such as the Duke Cancer Institute and the Duke Human Vaccine Institute. These units rely heavily on grants from the National Institutes of Health, which have been increasingly difficult to come by due to slowdowns in grant review processes, an uptick in terminations and a lack of new funding opportunities since President Donald Trump assumed office.
Under the guidelines, each department must establish a minimum expectation for external grant funding. Tenured faculty members who do not meet the threshold — measured as a three-year average — would be given the option to either enter a 12-month “Safe Harbor” period, after which further inability to meet productivity standards will result in salary reductions, or consider career transition alternatives.
One has to wonder if others will follow suit.